ITM, Powers

ITM Power's £86.5m Chronos Funding Fails to Spark Rally as Market Fixates on Execution Hurdles

Published on 07/12/2026 at 16:56 | Redaktion boerse-global.de

Despite an £86.5M UK government package for its Chronos electrolyser line, ITM Power shares fell 8.5% in a week, highlighting a stark disconnect between analyst optimism and market reality.

ITM Power: Government Funding Fails to Lift Shares as Market Scepticism Persists
ITM Power's £86.5m Chronos Funding Fails to Spark Rally as Market Fixates on Execution Hurdles Illustration mit AI erstellt übermittelt durch boerse-global.de

The disconnect between analyst optimism and market reality at ITM Power has rarely been starker. Berenberg raised its price target on the electrolyser maker to 200 pence on June 30, and the British government confirmed an £86.5 million support package for its Sheffield factory on July 9. Yet the shares ended last week at €1.35, down 1.95% on the day and 8.51% lower over the preceding seven days.

The funding itself is substantial. The Department for Energy Security and Net Zero (DESNZ) is providing a £46.5 million grant, while the state-backed investment vehicle Great British Energy is contributing a further £40 million in equity. The money is earmarked for a highly automated production line dedicated to ITM's "Chronos" electrolyser stacks, with a target annual capacity of 1 gigawatt. Automation is expected to lower unit costs and improve the reliability of the company's PEM technology — a critical advantage in the increasingly competitive green hydrogen space.

Yet the announcement triggered a classic "sell the news" reaction, as short-term profit-taking overwhelmed any longer-term enthusiasm. In the secondary article, one source noted that the market remains divided on how much the capital injection is actually worth, with analysts' assessments diverging noticeably.

Technical picture points to consolidation

The share price now sits just above its 100-day moving average of €1.33, which could provide support in the coming sessions. The 50-day moving average, by contrast, stands at €1.72 — a gap of 21.2% that underlines how far the stock has fallen from its late-May peak of €2.58, a 52-week high now 47.44% away. On the upside, the current level is 109.10% above the 52-week trough of €0.65 touched on February 6.

Should investors sell immediately? Or is it worth buying ITM Power?

The 14-day relative strength index of 42.0 suggests neutral-to-slightly-oversold conditions, rather than any extreme. More telling is the annualised 30-day volatility of 106.37%, a figure that highlights the acute nervousness surrounding the name. With a market capitalisation of roughly €933 million, ITM remains very much a speculative growth bet within the hydrogen sector.

Year-to-date the stock has still managed a gain of 86.77%, and over twelve months it is up 36.73%. Those figures, however, do little to mask the recent erosion of confidence.

Analyst split and sector headwinds

Berenberg's raised target stands out as a bullish outlier. The bank cited the newly secured Chronos funding as reason for its optimism. But the market has not followed suit: other analysts remain more cautious, and the stock's persistent weakness suggests the broader consensus is sceptical about ITM's ability to translate government support into sustainable profitability.

The sector itself is under pressure. The European Commission is working on a revised hydrogen strategy following a second-quarter consultation, and member states are applying the Renewable Energy Directive (RED III) criteria unevenly, creating fragmentation. Meanwhile, competitor HydrogenPro ASA opens a subscription period for a placing on July 13, a move that investors often use as a barometer of risk appetite across the electrolyser space.

ITM Power at a turning point? This analysis reveals what investors need to know now.

Cash cushion gives cover for long-term pivot

ITM's balance sheet provides some breathing room. Cash and equivalents stood at £197.8 million at the half-year mark, and the new funding bolsters that further. The central challenge remains the shift from loss-making research to profitable series production. Older, low-margin contracts continue to weigh on EBITDA, and whether the automated Sheffield line can relieve that pressure will only become clear as production ramps up.

Interim earnings for the financial year ending April 2026 are due in August. Until then, the integration of the state funding and the market's reaction to any further operational milestones will determine whether the stock can hold the €1.35 level — or whether the consolidation deepens. For now, the story is one of promise meeting patience, with the outcome far from settled.

Ad

ITM Power Stock: New Analysis - 12 July

Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ITM Power analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | GB00B0130H42 | ITM | boerse | 69754456 |